Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 308

1.

Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study.

Chitra P, Saiprasad G, Manikandan R, Sudhandiran G.

Toxicol Lett. 2013 May 23;219(2):178-93. doi: 10.1016/j.toxlet.2013.03.009.

PMID:
23523906
2.
3.

Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta.

Kalayarasan S, Sriram N, Sudhandiran G.

Life Sci. 2008 Jun 6;82(23-24):1142-53. doi: 10.1016/j.lfs.2008.03.018.

PMID:
18462759
4.

Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α and IL-1β.

Kandhare AD, Bodhankar SL, Mohan V, Thakurdesai PA.

Chem Biol Interact. 2015 Jul 25;237:151-65. doi: 10.1016/j.cbi.2015.06.019.

PMID:
26093215
5.

Hydrogen sulfide protects against bleomycin-induced pulmonary fibrosis in rats by inhibiting NF-κB expression and regulating Th1/Th2 balance.

Cao H, Zhou X, Zhang J, Huang X, Zhai Y, Zhang X, Chu L.

Toxicol Lett. 2014 Jan 30;224(3):387-94. doi: 10.1016/j.toxlet.2013.11.008.

PMID:
24269241
6.

Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice.

Zhu T, Zhang W, Xiao M, Chen H, Jin H.

Int J Mol Sci. 2013 Dec 3;14(12):23581-96. doi: 10.3390/ijms141223581.

7.

Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.

Gou S, Zhu T, Wang W, Xiao M, Wang XC, Chen ZH.

Int Immunopharmacol. 2014 Oct;22(2):498-504. doi: 10.1016/j.intimp.2014.07.010.

PMID:
25111852
8.

Berberine inhibits Smad and non-Smad signaling cascades and enhances autophagy against pulmonary fibrosis.

Chitra P, Saiprasad G, Manikandan R, Sudhandiran G.

J Mol Med (Berl). 2015 Sep;93(9):1015-31. doi: 10.1007/s00109-015-1283-1.

PMID:
25877860
9.

Attenuation of bleomycin-induced lung fibrosis in rats by mesna.

El-Medany A, Hagar HH, Moursi M, At Muhammed R, El-Rakhawy FI, El-Medany G.

Eur J Pharmacol. 2005 Feb 10;509(1):61-70.

PMID:
15713430
10.

Use of tetrandrine to differentiate between mechanisms involved in silica-versus bleomycin-induced fibrosis.

Ma JY, Barger MW, Hubbs AF, Castranova V, Weber SL, Ma JK.

J Toxicol Environ Health A. 1999 Jun 25;57(4):247-66.

PMID:
10406349
11.
12.

Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis.

Zhao L, Wang X, Chang Q, Xu J, Huang Y, Guo Q, Zhang S, Wang W, Chen X, Wang J.

Eur J Pharmacol. 2010 Feb 10;627(1-3):304-12. doi: 10.1016/j.ejphar.2009.11.007.

PMID:
19909737
13.

Atorvastatin attenuates bleomycin-induced pulmonary fibrosis via suppressing iNOS expression and the CTGF (CCN2)/ERK signaling pathway.

Zhu B, Ma AQ, Yang L, Dang XM.

Int J Mol Sci. 2013 Dec 16;14(12):24476-91. doi: 10.3390/ijms141224476.

14.

Evaluating the inhibitory potential of sulindac against the bleomycin-induced pulmonary fibrosis in wistar rats.

Verma R, Brahmankar M, Kushwah L, Suresh B.

Environ Toxicol Pharmacol. 2013 Nov;36(3):769-78. doi: 10.1016/j.etap.2013.07.011.

PMID:
23958969
15.
16.

Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced pulmonary fibrosis progression.

Tanaka R, Watanabe H, Kodama A, Chuang VT, Ishima Y, Hamasaki K, Tanaka K, Mizushima T, Otagiri M, Maruyama T.

J Pharmacol Exp Ther. 2013 May;345(2):271-83. doi: 10.1124/jpet.112.201814.

17.

Thymoquinone blocks lung injury and fibrosis by attenuating bleomycin-induced oxidative stress and activation of nuclear factor Kappa-B in rats.

El-Khouly D, El-Bakly WM, Awad AS, El-Mesallamy HO, El-Demerdash E.

Toxicology. 2012 Dec 16;302(2-3):106-13. doi: 10.1016/j.tox.2012.09.001.

PMID:
22982510
18.

VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.

Ou XM, Li WC, Liu DS, Li YP, Wen FQ, Feng YL, Zhang SF, Huang XY, Wang T, Wang K, Wang X, Chen L.

Int Immunopharmacol. 2009 Jan;9(1):70-9. doi: 10.1016/j.intimp.2008.10.002.

PMID:
18976720
19.

Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice.

Liu W, Wan J, Han JZ, Li C, Feng DD, Yue SJ, Huang YH, Chen Y, Cheng QM, Li Y, Luo ZQ.

Respir Res. 2013 Oct 8;14:101. doi: 10.1186/1465-9921-14-101.

20.

Protective Effect of Infliximab, a Tumor Necrosis Factor-Alfa Inhibitor, on Bleomycin-Induced Lung Fibrosis in Rats.

Altintas N, Erboga M, Aktas C, Bilir B, Aydin M, Sengul A, Ates Z, Topcu B, Gurel A.

Inflammation. 2016 Feb;39(1):65-78. doi: 10.1007/s10753-015-0224-z.

PMID:
26253295

Supplemental Content

Support Center